Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki, 859-3298, Japan.
School of Medicine and Pharmacy, Vietnam National University, 144 Xuan Thuy St., Cau Giay, Hanoi, Vietnam.
Phytother Res. 2015 Dec;29(12):1956-63. doi: 10.1002/ptr.5490. Epub 2015 Oct 14.
Recently, the resources of medicinal plants have been exhausting. The root of Angelica acutiloba is one of the most important ingredients in Japanese Kampo medicine for the treatment of gynecological diseases. In our search for alternative medicinal plant resources of the root of A. acutiloba, we found that its aerial part has the anti-inflammatory potency as well as the root. Phytochemical investigation of the aerial part resulted in the isolation of four compounds including a new dimeric phthalide, namely tokiaerialide (2), along with Z-ligustilide (1), falcarindiol (3), and bergaptol (4). Next, we investigated the in vitro anti-inflammatory activity of 1-4 in lipopolysaccharide-stimulated RAW264 macrophages. Among the isolated compounds, 1 exhibited the most potent inhibition against lipopolysaccharide-induced production of prostaglandin E2 , nitric oxide, and pro-inflammatory cytokines (interleukin-6 and tumor necrosis factor-α). Compounds 3 and 4 also inhibited all inflammatory mediators, but their inhibitory abilities were weaker than those of 1. Furthermore, 1, 3, and 4 strongly also induced heme oxygenase-1. These results suggest that 1, 3, and 4 potentially exert anti-inflammatory activity, and the aerial part of A. acutiloba may be considered to be a useful medicinal resource for inflammatory diseases.
最近,药用植物资源已经枯竭。当归根是日本汉方药治疗妇科疾病的最重要成分之一。在寻找当归根的替代药用植物资源的过程中,我们发现其地上部分具有抗炎作用,与根的作用相当。对地上部分的植物化学研究导致分离出了四种化合物,包括一种新的二聚苯酞,即当归醇(2),以及 Z-藁本内酯(1)、法卡林二醇(3)和 Bergaptol(4)。接下来,我们研究了 1-4 在脂多糖刺激的 RAW264 巨噬细胞中的体外抗炎活性。在分离出的化合物中,1 对脂多糖诱导的前列腺素 E2、一氧化氮和促炎细胞因子(白细胞介素-6 和肿瘤坏死因子-α)的产生具有最强的抑制作用。化合物 3 和 4 也抑制所有炎症介质,但它们的抑制能力弱于 1。此外,1、3 和 4 还强烈诱导血红素加氧酶-1。这些结果表明,1、3 和 4 可能具有抗炎活性,当归的地上部分可能被认为是治疗炎症性疾病的有用药用资源。